|
Name |
Ethyl 3-hydroxy-2,2-dimethylbutanoate
|
Molecular Formula | C8H16O3 | |
IUPAC Name* |
ethyl 3-hydroxy-2,2-dimethylbutanoate
|
|
SMILES |
CCOC(=O)C(C)(C)C(C)O
|
|
InChI |
InChI=1S/C8H16O3/c1-5-11-7(10)8(3,4)6(2)9/h6,9H,5H2,1-4H3
|
|
InChIKey |
DPZVLAWBYJYWFX-UHFFFAOYSA-N
|
|
Synonyms |
Ethyl 3-hydroxy-2,2-dimethylbutanoate; 69737-23-1; 7505-94-4; 3-Hydroxy-2,2-dimethylbutyric Acid Ethyl Ester; 3-HYDROXY-2,2-DIMETHYL-BUTYRIC ACID ETHYL ESTER; NSC402035; SCHEMBL79746; 3-Hydroxy-2,2-dimethyl-butanoic Acid Methyl Ester; Butanoic acid, 3-hydroxy-2,2-dimethyl-, ethyl ester; Ethyl3-hydroxy-2,2-dimethylbutanoate; AKOS011685328; NSC-402035; Ethyl 3-hydroxy-2,2-dimethylbutanoate #; CS-0278409; FT-0669547; EN300-91131; F73606
|
|
CAS | 7505-94-4 | |
PubChem CID | 344889 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 160.21 | ALogp: | 1.1 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.634 |
Caco-2 Permeability: | -4.357 | MDCK Permeability: | 0.00005980 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.087 |
30% Bioavailability (F30%): | 0.712 |
Blood-Brain-Barrier Penetration (BBB): | 0.959 | Plasma Protein Binding (PPB): | 33.38% |
Volume Distribution (VD): | 0.864 | Fu: | 72.01% |
CYP1A2-inhibitor: | 0.334 | CYP1A2-substrate: | 0.27 |
CYP2C19-inhibitor: | 0.159 | CYP2C19-substrate: | 0.857 |
CYP2C9-inhibitor: | 0.02 | CYP2C9-substrate: | 0.254 |
CYP2D6-inhibitor: | 0.021 | CYP2D6-substrate: | 0.401 |
CYP3A4-inhibitor: | 0.011 | CYP3A4-substrate: | 0.372 |
Clearance (CL): | 7.777 | Half-life (T1/2): | 0.587 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.033 |
Drug-inuced Liver Injury (DILI): | 0.177 | AMES Toxicity: | 0.022 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.124 | Carcinogencity: | 0.051 |
Eye Corrosion: | 0.225 | Eye Irritation: | 0.836 |
Respiratory Toxicity: | 0.02 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000186 | 0.424 | D0J5DC | 0.321 | ||||
ENC001245 | 0.400 | D0ZK8H | 0.306 | ||||
ENC000241 | 0.389 | D0Y6KO | 0.281 | ||||
ENC001045 | 0.359 | D08HZC | 0.263 | ||||
ENC000312 | 0.355 | D02KBD | 0.259 | ||||
ENC000814 | 0.355 | D0FM2P | 0.256 | ||||
ENC000719 | 0.353 | D04MWJ | 0.256 | ||||
ENC001015 | 0.333 | D07ZTO | 0.256 | ||||
ENC000224 | 0.324 | D05PLH | 0.254 | ||||
ENC000416 | 0.316 | D06YPU | 0.245 |